Age (years) [median (IQR)]
|
37 (29.0–48.0)
|
41 (31.0–52.0)
|
.03
|
Males [n (%)]
|
167 (86.5)
|
212 (80)
|
NS
|
Interval from presentation to TST (days) [median (IQR)]
|
6 (3.0–10.0)
|
7 (4.0–15.0)
|
.04
|
Chills [proportiona (%)]
|
118/124 (95.2)
|
115/125 (92.0)
|
NS
|
Myalgia [proportiona (%)]
|
113/120 (94.2)
|
148/166 (89.2)
|
NS
|
Jaundice [proportiona (%)]
|
41/175 (23.4)
|
27/222 (12.2)
|
<.01
|
Cough [proportiona (%)]
|
27/100 (27.0)
|
63/154 (40.9)
|
.02
|
Dyspnea [proportiona (%)]
|
15/105 (14.3)
|
15/109 (13.8)
|
NS
|
Nasal discharge [proportiona (%)]
|
3/36 (8.3)
|
16/55 (29.1)
|
.02
|
Nasal obstruction [proportiona (%)]
|
5/37 (13.5)
|
12/43 (27.9)
|
NS
|
Chest pain [proportiona (%)]
|
2/40 (5)
|
15/65 (23.1)
|
.01
|
Cervical lymphadenopathy [proportiona (%)]
|
4/57 (7)
|
24/88 (27.3)
|
<.01
|
Nausea [proportiona (%)]
|
58/112 (51.8)
|
42/114 (36.8)
|
.02
|
Vomiting [proportiona (%)]
|
60/136 (44.1)
|
31/129 (24.0)
|
<.01
|
Diarrhea [proportiona (%)]
|
22/136 (16.2)
|
52/157 (33.1)
|
<.01
|
Sore throat [proportiona (%)]
|
4/43 (9.3)
|
15/53 (28.3)
|
.02
|
Abdominal pain [proportiona (%)]
|
43/72 (59.7)
|
48/82 (58.5)
|
NS
|
Headache [proportiona (%)]
|
120/138 (87.0)
|
137/166 (82.5)
|
NS
|
Retro-orbital pain [proportiona (%)]
|
25/40 (62.5)
|
30/46 (65.2)
|
NS
|
Hepatomegaly [proportiona (%)]
|
35/184 (19.0)
|
38/327 (16.0)
|
NS
|
Splenomegaly [proportiona (%)]
|
20/183 (10.9)
|
18/237 (7.6)
|
NS
|
Feverb [proportiona (%)]
|
193/193 (100 %)
|
242/258 (93.8)
|
<.01
|